Samrat Remedies Limited - Company Profile

Q: Who are the current directors of Samrat Remedies Limited?

The current directors of Samrat Remedies Limited are Champaklal Kantilal Parekh, Hitesh Champak Parekh, Saroj Champaklal Parekh, Sangeeta Hitesh Parekh.

It is a pharma public limited company based in Mumbai, Maharashtra, India, established in 2003.

2003 Mumbai, Maharashtra, India Active

Last Updated: January 06, 2026

Access Report

About Samrat Remedies Limited

Samrat Remedies Limited, a active public limited company, was established on 21 August 2003 in Mumbai, Maharashtra, India. Engaging in api manufacturers within the manufacturing sector, it holds CIN: U24231MH2003PLC392453. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹1.50 Cr and a paid-up capital of ₹1.07 Cr.

It upholds a compliant status. Employing 21 professional, Its leadership includes Champaklal Kantilal Parekh (Whole-Time Director), Hitesh Champak Parekh (Managing Director), Saroj Champaklal Parekh (Whole-Time Director). Past directors included Champaklal Kantilal Parekh, Saroj Champaklal Parekh, Sangeeta Hitesh Parekh. It holds no open charges and ₹8.91 Cr settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at 208, 2Nd Floor, De Elmas, Pahadi Village, Sonawala Cross Lane No. 2, Goregaon East, ,, Mumbai, Maharashtra, 400063.

Company Details

CIN/LLPIN
U24231MH2003PLC392453
Registration Number
392453
Incorporation Date
21 August 2003
Authorized Capital
₹1.50 Cr
Paid-Up Capital
₹1.07 Cr
ROC Code
Roc Mumbai
Listing Status
Unlisted
Company Status
Active

Key Metrics

Authorised Capital ₹ 1.50 Cr as on 06-01-2026
Paid Up Capital ₹ 1.07 Cr as on 06-01-2026
Company Age 22 Year, 6 Months
Last Filing with ROC 31 Mar 2024
Satisfied Charges ₹ 8.91 Cr as on 06-01-2026
Revenue Growth **** 1861.96% (FY 2023)
Profit Growth **** 38626.42% (FY 2023)
Ebitda **** 2149.09% (FY 2023)
Net Worth 88.77% (FY 2023)
Total Assets **** 112.53% (FY 2023)

Comprehensive Company Insights

Explore comprehensive insights into Samrat Remedies Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report

Who are the key members and board of directors at Samrat Remedies Limited?

Current Directors

Name	Designation	Appointment Date	Status
Champaklal Kantilal Parekh	Whole-Time Director	25 Aug 2003	Current
Hitesh Champak Parekh	Managing Director	25 Aug 2003	Current
Saroj Champaklal Parekh	Whole-Time Director	16 Sep 2005	Current
Sangeeta Hitesh Parekh	Whole-Time Director	16 Sep 2005	Current

Past Directors

Name	Designation	Cessation	Status
Pramod Abcsdd	Director	01 Jan 2012	Past
Pramod Abcsdd	Director	01 Jan 2012	Past
Pramod Abcsdd	Director	01 Jan 2012	Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Samrat Remedies.

Samrat Remedies Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 1861.96% increase. The company also saw a substantial improvement in profitability, with a 38626.42% increase in profit. The company's net worth Soared by an impressive increase of 88.77%.

Date	Amount	Transaction Name	Valuation	Lead Investors	Investors
Jul, 2021	Amount	Post-IPO - Grab	Valuation	investors	Emtek
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners
Jan, 2021	Amount	Post-IPO - Grab	Valuation	investors	Hana Financial Group , GGV Capital
Feb, 2021	Amount	Post-IPO - Grab	Valuation	investors	Signite Partners

Upgrade Required

Full access to Financial is available only for users with an active Premium plan.

Key Matrics
Balance Sheet
Profit and Loss
Cash Flow
Ratios

Metrics

(FY 2023)

YOY Growth

(FY 2022)

(FY 2021)

(FY 2020)

(FY 2019)

Total Revenue

********

1861.96%

*******

Revenue from Operations

*******

27620.50%

*******

Total Assets

*******

112.53%

*******

Profit or Loss

*******

38626.42%

*******

Net Worth

*******

88.77%

*******

EBITDA

*******

2149.09%

*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Samrat Remedies?

In 2023, Samrat Remedies had a promoter holding of 96.60% and a public holding of 3.40%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)

Promoters: 92.83%
Public: 4.10%
Others: 3.07%

Shareholding Pattern over the Year

	FY (2024)	FY (2023)	FY (2022)	FY (2021)	FY (2020)
Promoters	92.83	94.62	94.55	94.55	94.55
Public	4.10	3.89	3.95	3.96	3.98
Others	3.07	1.49	1.50	1.49	1.47

Upgrade Required

Full access to Ownership and Shareholding Structure is available only for users with an active Premium plan.

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)

Open Charges

₹0

Satisfied Charges

₹89,050,000.00

Charges Breakdown by Lending Institutions

The Saraswat Co-Operative Bank Limited : 5.31 Cr
Others : 3.60 Cr

Latest Charge Details

Date	Lender	Amount	Status
09 Aug 2008	Others	₹3.60 Cr	Satisfied
30 Jan 2008	The Saraswat Co-Operative Bank Limited	₹5.55 M	Satisfied
15 Apr 2006	The Saraswat Co-Operative Bank Limited	₹1.50 Cr	Satisfied
15 Apr 2006	The Saraswat Co-Operative Bank Limited	₹3.25 Cr	Satisfied

Explore comprehensive loan charge details -

How Many Employees Work at Samrat Remedies?

Unlock and access historical data on people associated with Samrat Remedies, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Date	Number of Employees
2020	78,000
2021	80,500
2022	83,200
2023	86,000
2024	89,500
2025	92,000

Upgrade Required

Full access to People is available only for users with an active Premium plan.

Deals i

Gain comprehensive insights into the Deals and Valuation data of Samrat Remedies, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Samrat Remedies's trajectory.

Rating

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Samrat Remedies

Recent Activity within the Organization

Annual General Meeting

Samrat Remedies Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
30 Sep 2024
Balance Sheet

The activity Samrat Remedies Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was completed.
31 Mar 2024
Charges

A charge registered on 09 Aug 2008 via Charge ID 10133784 with Others was fully satisfied on 25 Mar 2022. was recorded as a recent event.
25 Mar 2022
Charges

A charge with Others of Rs. 3.60 Cr registered on 09 Aug 2008 with Charge ID 10133784 was modified on 23 Oct 2020. was recorded as a recent event.
23 Oct 2020
Charges

A charge registered on 30 Jan 2008 via Charge ID 10102043 with The Saraswat Co-Operative Bank Limited was fully satisfied on 17 Jan 2018. was recorded as a recent event.
17 Jan 2018
Charges

A charge registered on 15 Apr 2006 via Charge ID 80017200 with The Saraswat Co-Operative Bank Limited was fully satisfied on 17 Jan 2018. was recorded as a recent event.
17 Jan 2018

Explore recent activity and updates - View Recent Activity